Literature DB >> 24059443

Effects of interactive metronome therapy on cognitive functioning after blast-related brain injury: a randomized controlled pilot trial.

Lonnie A Nelson1, Margaret Macdonald, Christina Stall, Renee Pazdan.   

Abstract

OBJECTIVE: We report preliminary findings on the efficacy of interactive metronome (IM) therapy for the remediation of cognitive difficulties in soldiers with persisting cognitive complaints following blast-related mild-to-moderate traumatic brain injury (TBI).
METHOD: Forty-six of a planned sample of 50 active duty soldiers with persistent cognitive complaints following a documented history of blast-related TBI of mild-to-moderate severity were randomly assigned to receive either standard rehabilitation care (SRC) or SRC plus a 15-session standardized course of IM therapy. Primary outcome measures were Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Index Scores. Secondary outcome measures included selected subtests from the Delis-Kaplan Executive Functioning System (Trail Making Test and Color-Word Interference) and the Wechsler Adult Intelligence Scale-Fourth Edition (Symbol Search, Digit-Symbol Coding, Digit Span, and Letter-Number Sequencing) as well as the Integrated Visual and Auditory Continuous Performance Test.
RESULTS: Significant group differences (SRC vs. IM) were observed for RBANS Attention (p = .044), Immediate Memory (p = .019), and Delayed Memory (p = .031) indices in unadjusted analyses, with the IM group showing significantly greater improvement at Time 2 than the SRC group, with effect sizes in the medium-to-large range in the adjusted analyses for each outcome (Cohen's d = 0.511, 0.768, and 0.527, respectively). Though not all were statistically significant, effects in 21 of 26 cognitive outcome measures were consistently in favor of the IM treatment group (binomial probability = .00098).
CONCLUSION: The addition of IM therapy to SRC appears to have a positive effect on neuropsychological outcomes for soldiers who have sustained mild-to-moderate TBI and have persistent cognitive complaints after the period for expected recovery has passed. PsycINFO Database Record (c) 2013 APA, all rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24059443     DOI: 10.1037/a0034117

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  5 in total

1.  Home-Based Music Therapy to Support Bulbar and Respiratory Functions of Persons with Early and Mid-Stage Amyotrophic Lateral Sclerosis-Protocol and Results from a Feasibility Study.

Authors:  Alisa T Apreleva Kolomeytseva; Lev Brylev; Marziye Eshghi; Zhanna Bottaeva; Jufen Zhang; Jörg C Fachner; Alexander J Street
Journal:  Brain Sci       Date:  2022-04-13

2.  Cognitive Training for Post-Acute Traumatic Brain Injury: A Systematic Review and Meta-Analysis.

Authors:  Harry Hallock; Daniel Collins; Amit Lampit; Kiran Deol; Jennifer Fleming; Michael Valenzuela
Journal:  Front Hum Neurosci       Date:  2016-10-27       Impact factor: 3.169

3.  Effects of interactive metronome training on postural stability and upper extremity function in Parkinson's disease: a case study.

Authors:  Arim Kim; Hye-Sun Lee; Chiang-Soon Song
Journal:  J Phys Ther Sci       Date:  2017-01-30

4.  Study protocol for an online randomised controlled trial among non-treatment seeking problem gamblers: training inhibition in online problem gambling (TRAIN-online) trial.

Authors:  Antoine Santiago; Arnaud Carré; Ruben Miranda; Cédric Lemogne; Yann LeStrat; Amine Benyamina; Pascal Perney; Amandine Luquiens
Journal:  BMJ Open       Date:  2021-11-30       Impact factor: 2.692

5.  A randomized clinical trial of plasticity-based cognitive training in mild traumatic brain injury.

Authors:  Henry W Mahncke; Joseph DeGutis; Harvey Levin; Mary R Newsome; Morris D Bell; Chad Grills; Louis M French; Katherine W Sullivan; Sarah-Jane Kim; Annika Rose; Catherine Stasio; Michael M Merzenich
Journal:  Brain       Date:  2021-08-17       Impact factor: 15.255

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.